Selected article for: "positive epitope and SARS cov"

Author: Syed Faraz Ahmed; Ahmed A. Quadeer; Matthew R. McKay
Title: Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies
  • Document date: 2020_2_4
  • ID: 7i52vltp_19
    Snippet: For the expanded set of epitopes, all of which have at least one positive MHC binding assay, we found that 264 epitope-sequences have an identical match in SARS-CoV-2 proteins and have associated MHC allele information available (listed in Table S2 ). Of these 264 epitopes, ~80% were MHC Class I restricted epitopes (Table S3) The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.03.933226 do.....
    Document: For the expanded set of epitopes, all of which have at least one positive MHC binding assay, we found that 264 epitope-sequences have an identical match in SARS-CoV-2 proteins and have associated MHC allele information available (listed in Table S2 ). Of these 264 epitopes, ~80% were MHC Class I restricted epitopes (Table S3) The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.03.933226 doi: bioRxiv preprint alleles and was estimated to provide an accumulated population coverage of 96.29% (Table 3) . We also computed the population coverage of this specific set of epitopes in China, the country most affected by the COVID-19 outbreak, which was estimated to be slightly lower (88.11%) as certain MHC alleles (e.g., HLA-A*02:01) associated with some of these epitopes are less frequent in the Chinese population (Table 3) . Repeating the same greedy approach but focusing on the Chinese population, instead of a global population, the maximum population coverage was estimated to be 92.76% (Table S4 ).

    Search related documents:
    Co phrase search for related documents
    • global population and maximum population coverage: 1, 2, 3, 4
    • global population and MHC available allele information: 1
    • global population and population coverage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • greedy approach and population coverage: 1
    • HLA allele and maximum population coverage: 1
    • HLA allele and MHC HLA allele: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • HLA allele and population coverage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • HLA allele and SARS protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • identical match and SARS protein: 1
    • identical match and SARS protein identical match: 1
    • maximum population coverage and population coverage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • maximum population coverage and SARS protein: 1, 2
    • MHC available allele information and population coverage: 1
    • MHC available allele information and SARS protein: 1
    • MHC HLA allele and population coverage: 1, 2, 3
    • MHC HLA allele and SARS protein: 1, 2, 3
    • population coverage and SARS protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • population coverage and specific set: 1
    • SARS protein and specific set: 1, 2, 3